This inventor holds 5 USPTO granted patents. Top assignee: Cold Spring Harbor Laboratory. Active years: 1999-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2005
Title: Natalia I Peunova: Innovator in Hematopoietic Stem Cell Research
Introduction
Natalia I Peunova is a prominent inventor based in Cold Spring Harbor, NY (US). She has made significant contributions to the field of biomedical research, particularly in the area of hematopoietic stem cells. With a total of 5 patents to her name, her work has the potential to impact therapeutic approaches in regenerative medicine.
Latest Patents
Her latest patents focus on the therapeutic uses of nitric oxide inhibitors. The first patent outlines a method for increasing the population of hematopoietic stem cells in mammals by contacting hematopoietic tissue with nitric oxide synthase (NOS) inhibitors. This method aims to enhance normal hematopoiesis, differentiation, and maturation of these cells. Another patent describes a similar approach for regenerating tissue in adult mammals, emphasizing the role of nitric oxide in cell proliferation and differentiation. These innovations highlight the importance of nitric oxide as a growth regulator in developing organisms.
Career Highlights
Natalia I Peunova is affiliated with Cold Spring Harbor Laboratory, where she conducts her research. Her work has garnered attention for its potential applications in treating various medical conditions through the manipulation of hematopoietic stem cells.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Grigori N Enikolopov and Boris A Kuzin. These partnerships have further enriched her research and contributed to the advancement of knowledge in her field.
Conclusion
In summary, Natalia I Peunova is a distinguished inventor whose research on nitric oxide inhibitors and hematopoietic stem cells holds promise for future therapeutic applications. Her contributions continue to shape the landscape of biomedical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
